5 June 2014 Official Air Force Aerospace Medicine Approved ...

Azilsartan is an angiotensin II receptor antagonist indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents. The efficacy of azilsartan was studied in two large (> 1000 patients) randomized, double-blind, placebo- and active-controlled trials of 6 weeks in duration. ................
................